Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference:
https://conference.financialhearings.com/teleconference/?id=200794
The presentation will be webcast and can be accessed from the following web address:
https://ir.financialhearings.com/irras-q2-2023
Speakers: President and CEO
For more information, please contact:
President and Chief Executive Officer
ir@irras.com
About IRRAS
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in
IRRAS maintains its headquarters in
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
https://news.cision.com/irras/r/q2-report-2023---invitation-to-conference-call-and-audiocast,c3812129
https://mb.cision.com/Main/16550/3812129/2211402.pdf
(c) 2023 Cision. All rights reserved., source